บริษัท ศูนย์ห้องปฏิบัติการและวิจัยทางการแพทย์และการเกษตรแห่งเอเซีย จำกัด (มหาชน)SET: AMARC🇹🇭 TH

Financial Information

Key Financial Highlights

As at 2026-09-30 · Unit: M.Baht

Item20242025H1 20269M 2026
Total revenue348.76494.66240.73359.47
Net profit39.9158.5669.3394.13
Total assets641.51705.38728.22671.48
Total liabilities120.46103.49143.54122.01
Shareholders' equity521.05601.89584.68549.47
EPS (Baht)0.090.380.170.23
ROE (%)7.7128.2421.2118.89
ROA (%)6.4123.517.0115.5
Net profit margin (%)11.4432.0528.826.19
D/E (times)0.230.170.250.22
ItemY/E 2023Dec 2023Y/E 2024Dec 2024Y/E 2025Dec 20256M/2025Jun 20256M/2026Jun 2026
Cash And Cash Equivalents33.0230.3845.5674.79144.18
A/R Net47.9959.7954.5352.5761.36
Inventories10.1110.9512.812.5114.46
Current Assets195.16194.06262.08292.06236.84
PP&E Net382.02375.1382.39394.39418.62
Non-Current Assets453.51447.45443.3456.75491.38
Total Assets648.67641.51705.38748.81728.22
OD—————
A/P Net29.7843.539.7765.4775.88
Current portion of LT———4.07—
Current Liabilities65.5470.2654.8189.4195.31
Non-Current Liabilities68.8150.248.6845.9548.23
Total Liabilities134.34120.46103.49135.36143.54
Authorized Capital210210210210210
Paid-Up Capital210210210210210
Premium (Discount) on Share Capital275.84275.84275.84275.84275.84
Retained Earnings (Deficit)28.4935.21116.05127.6298.85
Treasury Stock—————
Shares Of The Company Held By Subsidiaries—————
Other Components Of Equity—————
- Surplus (Deficits)—————
Shareholders' Equity514.33521.05601.89613.45584.68
Minority Interest—————

Auditor's Reports

ReportDate of submissionAuditor’s opinionAuditor’s firm
Q2 /202611 Aug 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Q1 /202612 May 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Yearly 202518 Feb 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Q3 /202512 Nov 2025Unqualified opinionDHARMNITI AUDITING CO., LTD.